On September 28, the Board of Directors of China Biologic Products, Inc. appointed Charles (Le) Zhang as a director of the company, effective from October 1, 2012. Mr. Charles Zhang has served as a Partner of DT Capital Partners since 2008. Mr. Zhang also served as a Senior Associate at Goldman Sachs Gao Hua Securities from 2006 to 2008, a senior manager at Huwei Technologies from 2000 to 2004 and a product manager at Alcatel from 1998 to 2000.
China Biologic Products Holdings, Inc.
Equities
CBPO
KYG215151047
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.61% | 21.96B | |
-8.98% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |